LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Hospital Universitario de Donostia
San Sebastián, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Donostia (14)
2024
-
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations
Frontiers in Psychology, Vol. 15
2023
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2022
-
Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Journal of Translational Medicine, Vol. 20, Núm. 1
-
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Frontiers in Neurology, Vol. 13
-
Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes
Parkinsonism and Related Disorders, Vol. 94, pp. 67-78
2016
2015
-
Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722
2013
-
Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene
Parkinsonism and Related Disorders, Vol. 19, Núm. 1, pp. 95-100
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
2010
-
Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the α-synuclein gene (SNCA)
Clinical Autonomic Research, Vol. 20, Núm. 4, pp. 267-269
-
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)
Movement Disorders, Vol. 25, Núm. 14, pp. 2340-2345
2009
-
Levodopa-induced dyskinesias in parkinson disease are independent of the extent of striatal dopaminergic denervation: A pharmacological and SPECT study
Clinical Neuropharmacology, Vol. 32, Núm. 6, pp. 326-329